Comparison of the efficacy of two different glucocorticoid regimens for treatment of active moderate-to-severe Graves’ orbitopathy

被引：0
|
作者：
Mariya Asenova Stoynova
Alexander Dimitrov Shinkov
Inna Dimitrova Dimitrova
Inna Angelova Yankova
Roussanka Dimitrova Kovatcheva
机构：
[1] Medical University of Sofia,Department of Endocrinology
[2] University Hospital of Endocrinology,undefined
来源：
International Ophthalmology | 2023年 / 43卷
关键词：
Graves’ orbitopathy; Glucocorticoid regimens; Efficacy; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4747 / 4757
页数：10
相关论文
共 50 条
  • [21] Active Moderate-to-Severe Graves' Orbitopathy in a Patient With Type 2 Diabetes Mellitus and Vascular Complications
    Urselli, Francesca
    Pontieri, Gilda
    Peschi, Livia
    Liccardi, Alessia
    Ruggiero, Anna Rita
    Biondi, Bernadette
    FRONTIERS IN ENDOCRINOLOGY, 2019, 9
  • [22] Predictive Factors for Changes in Quality of Life after Steroid Treatment for Active Moderate-to-Severe Graves' Orbitopathy: A Prospective Trial
    Hoppe, Elena
    Lee, Alan Chun Hong
    Hoppe, David
    Kahaly, George J.
    EUROPEAN THYROID JOURNAL, 2021, 9 (06) : 313 - 320
  • [23] Is concomitant treatment with steroids and radiotherapy more favorable than sequential treatment in moderate-to-severe graves orbitopathy?
    Paolo P. Limone
    Lavinia Bianco
    Marco Mellano
    Francesca Garino
    Fabiana Giannoccaro
    Annalisa Rossi
    Claudia Airaldi
    Daniela Nassisi
    Eva Gino
    Maurilio Deandrea
    Bruno Oldani
    Maria Grazia Ruo Redda
    La radiologia medica, 2021, 126 : 334 - 342
  • [24] Is concomitant treatment with steroids and radiotherapy more favorable than sequential treatment in moderate-to-severe graves orbitopathy?
    Limone, Paolo P.
    Bianco, Lavinia
    Mellano, Marco
    Garino, Francesca
    Giannoccaro, Fabiana
    Rossi, Annalisa
    Airaldi, Claudia
    Nassisi, Daniela
    Gino, Eva
    Deandrea, Maurilio
    Oldani, Bruno
    Ruo Redda, Maria Grazia
    RADIOLOGIA MEDICA, 2021, 126 (02): : 334 - 342
  • [25] Efficacy of Tocilizumab in Patients With Moderate-to-Severe Corticosteroid-Resistant Graves Orbitopathy: A Randomized Clinical Trial
    Perez-Moreiras, Jose, V
    Gomez-Reino, Juan J.
    Maneiro, Jose R.
    Perez-Pampin, Eva
    Romo Lopez, Angel
    Rodriguez Alvarez, Fernando M.
    Castillo Laguarta, Jesus M.
    del Estad Cabello, Aurora
    Gessa Sorroche, Maria
    Espana Gregori, Enrique
    Sales-Sanz, Marco
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2018, 195 : 181 - 190
  • [26] Comparison of two different regimens of intravenous methylprednisolone for patients with moderate to severe and active Graves' ophthalmopathy: a prospective, randomized controlled trial
    He, Yebing
    Mu, Ketao
    Liu, Rong
    Zhang, Jing
    Xiang, Nan
    ENDOCRINE JOURNAL, 2017, 64 (02) : 141 - 149
  • [27] Optimization of the treatment of moderate to severe and active thyroid orbitopathy considering the recommendations of the European Group on Graves' Orbitopathy (EUGOGO)
    Nowak, Mariusz
    Marek, Bogdan
    Kos-Kudla, Beata
    Sieminska, Lucyna
    Londzin-Olesik, Magdalena
    Glogowska-Szelag, Joanna
    Nowak, Wojciech
    Kajdaniuk, Dariusz
    ENDOKRYNOLOGIA POLSKA, 2022, 73 (04) : 756 - 777
  • [28] RETRACTION: Efficacy and safety of mycophenolate mofetil in patients with active moderate-to-severe Graves' orbitopathy (Retraction of Vol 86, Pg 247, 2017)
    Ye, X.
    Bo, X.
    Hu, X.
    CLINICAL ENDOCRINOLOGY, 2023, 98 (05) : 743 - 743
  • [29] Misfortunes do not come in pairs in patients with active moderate-to-severe Graves' orbitopathy (vol 134, 16773, 2024)
    不详
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2024, 134 (7-8):
  • [30] Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves' orbitopathy?
    Bartalena, L.
    Veronesi, G.
    Krassas, G. E.
    Wiersinga, W. M.
    Marcocci, C.
    Marino, M.
    Salvi, M.
    Daumerie, C.
    Bournaud, C.
    Stahl, M.
    Sassi, L.
    Azzolini, C.
    Boboridis, K. G.
    Mourits, M. P.
    Soeters, M. R.
    Baldeschi, L.
    Nardi, M.
    Curro, N.
    Boschi, A.
    Bernard, M.
    von Arx, G.
    Perros, P.
    Kahaly, G. J.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2017, 40 (05): : 547 - 553
12345